youtube-channel-logo

  • Vietnamese (VN)
  • English (UK)
  1. Products search
  2. News search
  • Home
    • Câu chuyện kể về DHG
  • About Us
    • Our History
    • Our Values, Mission & Vision
    • Domestic Distribution
  • News
  • Activities
  • Products
    • Analgesic - Antipyretic
    • Ear - Nose - Throat, Cough, Asthma
    • Ophthalmic - Nervous
    • Muscular, Osteoarticular
    • Digestive
    • Hepatic
    • Cardiovascular - Diabetic
    • Supplemental Alimentary Product
    • Dermal - Beauty Care
  • Overview
  • Export
  • Investor Relations
    • Announcement
    • Annual General Meeting (AGM)
    • Annual Report
    • Financial report
    • IR News
    • Corporation regulations
    • Management Regulations
  • Contact


  • Home
  • Investor Relations
  • Annual Report

Investor Relations

  • Announcement
  • Annual General Meeting (AGM)
    • 2019
    • 2018
      • Annual General Meeting in 2017
    • 2017
      • General Meeting of Shareholders by solicitation of written consent in 2017
    • 2016
      • Annual General Meeting in 2016 ​
  • Annual Report
  • Financial report
  • IR News
Title Published Date
Sustainable Development Report 2018 01 October 2019
Annual Report 2018 DHG Pharma 14 July 2019
Sustainable Development Report 2017 13 August 2018
Annual Report 2017 DHG Pharma 12 June 2018
Sustainable Development Report 2016 21 June 2017
Annual Report 2016 DHG Pharma 25 May 2017
Sustainable Development Report 2015 06 June 2016
Annual Report 2015 DHG Pharma 14 May 2016
Annual Report 2014 DHG Pharma 27 May 2015
Annual Report 2013 02 June 2014

Page 1 of 2

  • 1
  • 2

Knowledge

  • Medical information
  • Nutrition
  • Children's health
  • Women's health
  • Men's health
  • Elderly's health

Activity Brands

  • Hapacol
  • Eyelight
  • Spivital
  • Naturenz
  • NattoEnzym

News

Information disclosure on the appointmen…

Invitation to “Shareholder & Investo…

Consolidated financial statements and se…

Information disclosure on the changes in…

Sustainable Development Report 2018

DHG Pharma Reviewed Financial Statements…

Report on results of transaction in shar…

Notice of transaction in shares of Trade…

Report on corporate governance of DHG Ph…

Information disclosure on the retirement…

Consolidated financial statements and se…

Annual Report 2018 DHG Pharma

Information disclosure on signing the au…

Information disclosure about the change …

Information disclosure about last regist…

Information disclosure on the election o…

Invitation to “Shareholder & Investo…

Information disclosure about the documen…

Report on results of transaction in shar…

Consolidated financial statements and se…

Notice of transaction in shares of relat…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on results of transaction in shar…

Report on tender offer results of Taisho…

Information disclosure about the last re…

Information disclosure on the BOD resolu…

Explanation of business results for the …

The link of Annual Report 2018

Notice of transaction in shares of relat…

Notice regarding offering the share capi…

Notice of transaction in shares of inter…

Notice of transaction in shares of inter…

Report on results of transaction in shar…

Information disclosure on the extension …

Audited Financial Statements in 2018

Information disclosure on the BOD resol…

Notice of transaction in shares of relat…

Notice of transaction in shares of relat…

Notice of transaction in shares of relat…

Notice of transaction in shares of inter…

Contact Information

DHG PHARMA Corp

288 Bis Nguyen Van Cu Street-

Ninh Kieu District, Can Tho City

Tel : (+84)(0292) 891.433

Fax: (+84)(0292).895.209

Email: dhgpharma@dhgpharma.com.vn

 


Copyright by DHG PHARMA Corp. All rights reserved.

 

Back to top